HOME >> MEDICINE >> NEWS
UC Berkeley study finds in utero arsenic exposure tied to lung disease and cancer in adults

is particularly prevalent in Region II, a province in the north of Chile and one of the driest places on earth. In 1958, the cities there of Antofagasta and neighboring Mejillones tapped into arsenic-laden rivers to supply their growing populations with water. For the next 13 years, until an expensive arsenic removal plant was installed, the water supply for all residents in the cities was laced with an average of 860 micrograms per liter of arsenic. In contrast, the standard for arsenic in drinking water in the United States was recently dropped from 50 micrograms per liter to 10 micrograms per liter, with compliance required in 2006. (A microgram is a millionth of a gram.)

With such clear-cut exposure to arsenic, the unfortunate Chilean cities became a tragic natural experiment for studying the effects of arsenic on humans.

From earlier work he and others conducted in India, Smith knew that arsenic is associated with bronchiectasis, a rare lung disease that causes distortion and dilation of the bronchi, eventually leading to chronic infections. A study involving death certificates for young adults in Antofagasta and Mejillones, Smith realized, would reveal whether lung cancer and bronchiectasis could also occur as a result of childhood exposure to arsenic. Working with colleagues Guillermo Marshall and Catterina Ferreccio from the Pontificia Universidad Catlica de Chile in Santiago, Smith compared the death rates from 1989 to 2000 of young adults in the two cities with the rates in the rest of Chile, outside of Region II. The team focused on two groups: those born between 1951 and 1958, when the water supply to the cities had relatively low arsenic concentrations, and those born during the high-exposure period of 1958 to 1971.

Both groups, they reasoned, would have been exposed to high levels of arsenic throughout some or most of their childhoods, but the second group would also have been exposed in utero, that is, while in the womb. Exposure
'"/>

Contact: Liese Greensfelder
lieseg@berkeley.edu
530-643-7741
University of California - Berkeley
27-Mar-2006


Page: 1 2 3

Related medicine news :

1. New long-distance wireless networking developed at UC Berkeley brings eye care to India
2. UC Berkeley team helps win approval for life-saving drug for African women
3. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
4. Penn study finds pro-death proteins required to regulate healthy immune function
5. New study shows promise in reducing surgical risks associated with surgical bleeding
6. New study counts the economic cost of persistent pain in Australia
7. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
8. Most seniors now have drug coverage, U-M study shows
9. To gain muscle and lose fat, drink milk: study
10. Wheres the beef? Not enough of it is on elders plates, muscle-metabolism study suggests
11. Even older women at high risk have little interest in being tested for HIV, study finds

Post Your Comments:
(Date:5/21/2013)... Spring is the perfect time to ... filled with whole foods to weather perfect for outdoor ... season the nutrition experts at Brilliant Nutrition highlight five ... , 1. Eating Locally, With the abundance of fresh ... and explore, spring is a great time to take ...
(Date:5/21/2013)... Standard advice for mattress shoppers often consists ... given industry’s less than exceptional satisfaction ratings and the ... Consumer Mattress Reports sets out to revise this advice ... .” , This article addresses several components of the ... not be readily apparent to many shoppers. From prices ...
(Date:5/21/2013)... Patients of Dr. Michael Shenk and Dr. Judd Shenk ... gum disease and would like permanent tooth replacements now have ... laser gum surgery. Gum disease must be treated prior ... of all tooth replacement options. , The Laser Assisted ... by the Food and Drug Administration (FDA) that greatly improves ...
(Date:5/21/2013)... analogues (PGAs), drugs which lower intraocular pressure, are often ... but their use is not without risks. PGAs have ... eye color and other side effects. Now a new ... and lower eyelid drooping and other issues that can ... PLOS ONE . , Researchers from the Massachusetts Eye ...
(Date:5/21/2013)... 2013 HealthSmart continues to grow through ... has required the hiring of new talent in several ... to announce that Dawn Powell has joined the organization ... Director of Account Management in the Central Region and ... Texas. With extensive client management, employee benefits, and product ...
Breaking Medicine News(10 mins):Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3Health News:Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article 2Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2Health News:Glaucoma drug can cause droopy eyelids 2Health News:New Talent Joins the HealthSmart Account Management Team 2
(Date:5/21/2013)... May 21, 2013 BioElectronics Corp. (PINKSHEETS: ... electronic devices, announced that CEO, Andrew ... the FDA,s Medical Advisory Committee, Orthopedic and Rehabilitation ... for over the counter sales. "It,s ... medical device classification schema," Whelan said.  "While the ...
(Date:5/21/2013)... TARRYTOWN, N.Y. , May 21, 2013 ... Inc. (NASDAQ: REGN) today announced that the New ... Phase 2a study results of dupilumab (SAR231893/REGN668) in patients ... antibody targeting the alpha subunit of the interleukin 4 ... and IL-13, drivers of Th2 (Type 2 helper T ...
(Date:5/21/2013)... 2013 U.S. spending on specialty prescription drugs ... as cancer, multiple sclerosis and rheumatoid arthritis — is ... 2015, according to a forecast released today by Express ... ) "As we see what,s on ... to act so they can continue to offer an ...
Breaking Medicine Technology:BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 2U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 3U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 4U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 5
Cached News: